We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+5.33%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.83B
AUM Growth
+$233M
Cap. Flow
+$131M
Cap. Flow %
4.64%
Top 10 Hldgs %
38.82%
Holding
108
New
54
Increased
16
Reduced
13
Closed
25

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$123M
2
INCY icon
Incyte
INCY
+$96M
3
EHC icon
Encompass Health
EHC
+$82.4M
4
WOOF icon
Petco
WOOF
+$73.5M
5
ZTS icon
Zoetis
ZTS
+$66.8M

Top Sells

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$100M
2
COO icon
Cooper Companies
COO
+$88.2M
3
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$86.9M
4
BIO icon
Bio-Rad Laboratories Class A
BIO
+$81.7M
5
BMY icon
Bristol-Myers Squibb
BMY
+$80.5M

Sector Composition

Rank Sector Weight
1 Healthcare 83.85%
2 Real Estate 4.52%
3 Consumer Discretionary 2.42%
4 Financials 1.56%
5 Technology 1.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVRO
101
DELISTED
NEVRO CORP.
NVRO
– –
-156,046
Closed -$27M
ITCI
102
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-55,150
Closed -$1.75M
CTLT
103
DELISTED
CATALENT, INC.
CTLT
– –
-270,250
Closed -$28.1M
DCPH
104
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-139,210
Closed -$7.95M
SYNH
105
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-793,320
Closed -$54M
ALXN
106
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-61,330
Closed -$9.58M
FPRX
107
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-86,930
Closed -$1.48M
HZNP
108
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-400,000
Closed -$29.3M
1 2 3 4
5

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q1 2021 Portfolio in Review

As of Q1 2021, HealthCor Management held 108 positions worth $2.83B, up 9% from $2.59B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

HealthCor Management deployed $131M of net new capital in Q1 2021, opening 54 new positions and adding to 16 existing holdings. Its largest new stake was Danaher: 604,236 shares worth $121M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 92% a quarter earlier, followed by Real Estate and Consumer Discretionary.

On the sell side, the largest reduction was Cooper Companies, an estimated $88.2M trimmed.

  • HealthCor Management's largest Q1 2021 buy was Danaher: 604,236 shares worth $121M.
  • HealthCor Management added most to Incyte in Q1 2021, an estimated $96M increase.
  • HealthCor Management's biggest Q1 2021 reduction was Cooper Companies, cutting an estimated $88.2M.
  • HealthCor Management fully exited Madrigal Pharmaceuticals in Q1 2021, selling an estimated $100M.
  • HealthCor Management's ten largest holdings make up 39% of its $2.83B portfolio in Q1 2021.
  • HealthCor Management opened 54 new positions and closed 25 in Q1 2021.
  • HealthCor Management's portfolio value rose 9% quarter-over-quarter to $2.83B.

Based on HealthCor Management's 13F filing for Q1 2021, filed 17 May 2021.